Tirzepatide

Tirzepatide (also referenced in the literature as LY3298176) is a lyophilized research peptide that functions as a dual agonist at two key incretin receptors: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). Its bifunctional receptor profile distinguishes it from single-receptor incretin peptides and has made it a compound of significant interest across metabolic and endocrinological research.

Supplied as a lyophilized powder with a verified purity of ≥99% by HPLC, Tirzepatide is produced under stringent quality conditions suited to demanding biochemical research applications.

Research background

Tirzepatide has been studied extensively in the context of metabolic signalling, with particular focus on its simultaneous engagement of GLP-1 and GIP receptor pathways. In preclinical and biochemical research models, it has been investigated in relation to:

• Glucose metabolism and insulin secretion dynamics
• Appetite regulation and energy balance mechanisms
• Metabolic homeostasis and fat oxidation pathways
• Incretin-based signalling as a framework for understanding endocrine crosstalk

Its dual incretin receptor activity makes it a frequently referenced compound in studies exploring the comparative pharmacology of GLP-1 and GIP receptor systems.

Reconstitution & handling

Tirzepatide is supplied as a lyophilized powder and should be reconstituted with bacteriostatic water (BAC water) prior to use. Add an appropriate volume of BAC water directly to the vial, then gently swirl until the powder is fully dissolved. Do not shake the vial, as mechanical agitation may compromise peptide integrity. All handling should be conducted under aseptic conditions using appropriate laboratory equipment.

Storage & stability

The lyophilized powder should be stored refrigerated and protected from light and moisture. Once reconstituted, the solution should be kept refrigerated and used within a short timeframe to preserve activity and minimise degradation. Repeated freeze-thaw cycles of the reconstituted solution should be avoided.

Every order of Tirzepatide is accompanied by a batch-specific Certificate of Analysis (CoA), confirming identity and purity as tested by HPLC.